---
figid: PMC9663296__41417_2022_501_Fig7_HTML
pmcid: PMC9663296
image_filename: 41417_2022_501_Fig7_HTML.jpg
figure_link: /pmc/articles/PMC9663296/figure/Fig7/
number: Fig. 7
figure_title: Nrf2 overexpression inhibited RFC4 expression by activating the JNK/NF-
  κB signaling pathway
caption: A, C, E After 24 h of THP-1/U93/MV4-11 cells treated with 2.5 μM SC75741
  or not, western blot evaluated Nrf2, RFC4, c-Jun, p-c-Jun, p65, p-p65, JNK, and
  p-JNK protein expression in the Nrf2 overexpression group and the EV group. B, D,
  F The relative gray values were shown in histogram. Results represented the mean ± SD
  from 3 separate assays. ***P < 0.001, **P < 0.01, *P < 0.05.
article_title: Nrf2 overexpression increases the resistance of acute myeloid leukemia
  to cytarabine by inhibiting replication factor C4.
citation: Tianzhen Hu, et al. Cancer Gene Ther. 2022;29(11):1773-1790.
year: '2022'

doi: 10.1038/s41417-022-00501-1
journal_title: Cancer Gene Therapy
journal_nlm_ta: Cancer Gene Ther
publisher_name: Nature Publishing Group US

keywords:
- Leukaemia
- Gene expression

---
